XNAS · GOSS
+0.51% · +$0.0500 · Vol Not reported
Pre-market · updated 08:47:02 ET
Gossamer Bio, Inc. Common Stock

Gossamer Bio, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$9.93
Card
Relationship Map

Follow $GOSS

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $GOSS by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
GOSS
Gossamer Bio, Inc. Common Stock
Thu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Thu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GOSS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GOSS catalysts
About Gossamer Bio, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2019
Employees
162
Country
US

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.88
Last session
Day high
$9.88
Last session
Day low
$9.88
Last session
Previous close
$9.88
52W high
$303.20
-96.72% from high
52W low
$9.88
0% of range
Market cap
$60.4M
EPS
$-0.6600
Beta
1.46
Shares out
6.1M
Avg volume
263.5K
VWAP
$9.88
Last session
Price history computed in-house
1W
-7.28%
1M
-22.28%
3M
-26.86%
1Y
-95.15%
YTD
-96.00%
SMA 50 $12.52 · below
SMA 200 $59.00 · below
52W position 0%

GOSS overview

Veridion Score
59
Registered · 2026-10-08
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GOSS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GOSS Form 4 filings
Public disclosures

Congress activity in GOSS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

GOSS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GOSS in this window.
Lobbying spend

GOSS lobbying filings, year to date.

Registered lobbying filings matched to Gossamer Bio, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GOSS in this window.
Loading news for GOSS
Analyst ratings
Sovereign unlock shows live analyst consensus for GOSS.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.